Skip to main content
Have a personal or library account? Click to login
Efficacy of thyroid cyst sclerotherapy with polidocanol Cover

Efficacy of thyroid cyst sclerotherapy with polidocanol

Open Access
|May 2026

References

  1. Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. European Thyroid Association Guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: The EU-TIRADS. Eur Thyroid J 2017; 6: 225-37. doi: 10.1159/000478927
  2. Studen KB, Domagała B, Gaberšček S, Zaletel K, Hubalewska-Dydejczyk A. Diagnosing and management of thyroid nodules and goiter - current perspectives. Endocrine 2025; 87: 39-47. doi: 10.1007/S12020-024-04015-8
  3. Feldkamp J, Grünwald F, Luster M, Lorenz K, Vorländer C, Führer D. Non-surgical and non-radioiodine techniques for ablation of benign thyroid nodules: Consensus statement and recommendation. Exp Clin Endocrinol Diab 2020; 128: 687-92. doi: 10.1055/A-1075-2025
  4. Durante C, Hegedüs L, Czarniecka A, Paschke R, Russ G, Schmitt F, et al. 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management. Eur Thyroid J 2023; 12: e230067. doi: 10.1530/ETJ-23-0067
  5. Bennedbæk FN, Hegedüs L. Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol Metab 2003; 88: 5773-7. doi: 10.1210/JC.2003-031000
  6. Yang CC, Hsu Y, Liou JY. Efficacy of ethanol ablation for benign thyroid cysts and predominantly cystic nodules: a systematic review and meta-analysis. Endocrinol Metab 2021; 36: 81-95. doi: 10.3803/ENM.2020.833
  7. Scappaticcio L, Ferrazzano P, Di Martino N, Negro R, Deandrea M, Maiorino MI, et al. Prevalence and management of complications of percutaneous ethanol injection for cystic thyroid nodules: A systematic review of literature and meta-analysis. Thyroid 2024; 34: 1068-81. doi: 10.1089/THY.2024.0241
  8. Gong X, Wang F, Du H, Chen X, Shi B. Comparison of ultrasound-guided percutaneous polidocanol injection versus percutaneous ethanol injection for treatment of benign cystic thyroid nodules. J Ultrasound Med 2018; 37: 1423-9. doi: 10.1002/JUM.14482
  9. Gong X, Zhou Q, Wang F, Wu W, Chen X. Clinical study efficacy and safety of ultrasound-guided percutaneous polidocanol sclerotherapy in benign cystic thyroid nodules: Preliminary results. Int J Endocrinol 2017: 2017: 8043429. doi: 10.1155/2017/8043429
  10. Gong X, Zhou Q, Chen S, Wang F, Wu W, Chen X. Efficacy and safety of ultrasound-guided percutaneous polidocanol sclerotherapy in benign predominantly cystic thyroid nodules: a prospective study. Curr Med Res Opin 2017; 33: 1505-10. doi: 10.1080/03007995.2017.1325732
  11. Dong YJ, Liu ZH, Zhou JQ, Zhan WW. Efficacy of lauromacrogol injection for ablation of benign predominantly cystic thyroid nodules and related factors:a prospective study. Korean J Radiol 2022; 23: 479-87. doi: 10.3348/KJR.2020.1205
  12. Gao K, Dai W, Wang F, He S. Efficacy assessment and analysis of related factors of ultrasound-guided percutaneous lauromacrogol injection for cystic thyroid nodules. J Ultrasound Med 2023; 42:1093-101. doi: 10.1002/jum.16123.
  13. Chen L, Wang X, Liu Y, Zhang W, Zhang R, Cai R, et al. Polidocanol retention therapy for benign predominantly cystic thyroid nodules: analysis of efficacy, safety, and factors influencing short-term efficacy: a single-center exploratory study. J Surg Res 2025; 317: 380-8. doi: 10.1016/j.jss.2025.11.041
  14. Yang S, Huang D. Application of ultrasound-guided microwave ablation combined with polidocanol injection in benign cystic-solid thyroid nodules and recurrence analysis. Discov Onc 2025; 16: 736. doi: 10.1007/s12672-025-02533-z
  15. Min X, Zhang Z, Chen Y, Zhao S, Ge J, Zhao H, et al. Comparison of the effectiveness of lauromacrogol injection for ablation and microwave ablation in the treatment of predominantly cystic thyroid nodules: a multicentre study. BMC Cancer 2023; 23: 785. doi: 10.1186/s12885-023-11301-7
  16. Idiz UO, Aysan E, Can I, Buyukpinarbasili N, Yardimci EY, Bektasoglu H. The effects of lauromacrogol on thyroid tissue in rabbits. Is this a safe option for the treatment of nodular thyroid disease? Ann Ital Chir 2016; 87: 192-7. PMID: 27179294
  17. Ebrahimi SRS, Enamzadeh E, Babaei H. An evidence-based review of off-label uses of polidocanol. Curr Clin Pharmacol 2018; 12: 223-30. doi: 10.2174/1574884713666180223121828
  18. Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, Paciaroni A, et al. The natural history of benign thyroid nodules. JAMA 2015; 313: 926-35. doi: 10.1001/jama.2015.0956.
  19. Franceschi C, Ostan R, Mariotti S, Monti D, Vitale G. The aging thyroid: a reappraisal within the geroscience integrated perspective. Endocr Rev 2019; 40: 1250-70. doi: 10.1210/ER.2018-00170
DOI: https://doi.org/10.2478/raon-2026-0024 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Submitted on: Oct 11, 2026
Accepted on: Feb 5, 2026
Published on: May 14, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Ziga Mercun, Laura Martinjak, Edvard Pirnat, Simona Gaberscek, Katja Zaletel, Katica Bajuk Studen, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

AHEAD OF PRINT